John R. Langridge

Person

Edinburgh, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Sustained release ranolazine formulations
- Patent number 6,620,814
- Issue date Sep 16, 2003
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release ranolazine formulations
- Patent number 6,617,328
- Issue date Sep 9, 2003
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release ranolazine formulations
- Patent number 6,525,057
- Issue date Feb 25, 2003
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release ranolazine formulations
- Patent number 6,503,911
- Issue date Jan 7, 2003
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release ranolazine formulations
- Patent number 6,369,062
- Issue date Apr 9, 2002
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for administering a sustained release ranolanolazine formula...
- Patent number 6,303,607
- Issue date Oct 16, 2001
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Long acting calcium channel blocker composition
- Patent number 5,209,933
- Issue date May 11, 1993
- Syntex (U.S.A.) Inc.
- Calum B. MacFarlane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Sustained release ranolazine formulations
- Publication number 20060217397
- Publication date Sep 28, 2006
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20060147521
- Publication date Jul 6, 2006
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20040097514
- Publication date May 20, 2004
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20040029890
- Publication date Feb 12, 2004
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20030099705
- Publication date May 29, 2003
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20030100566
- Publication date May 29, 2003
- CV Therapeutics, Inc.
- Andrew A. Wolff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20020090396
- Publication date Jul 11, 2002
- CV Therapeutics, Inc.
- Andrew A. Wolff
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC
Information Patent Application
Sustained release ranolazine formulations
- Publication number 20020004506
- Publication date Jan 10, 2002
- CV Therapeutics, Inc.
- Andrew A. Wolff
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC

John R. Langridge

Person

Patents Grantslast 30 patents

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Method for administering a sustained release ranolanolazine formula...

Long acting calcium channel blocker composition

Patents Applicationslast 30 patents

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations

Sustained release ranolazine formulations